dimyristoylphosphatidylglycerol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4650 | 61361-72-6 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Chills | 63.01 | 53.89 | 26 | 423 | 160208 | 79583731 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 1.19 | acidic |
| pKa2 | 13.63 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| C0058291 | UMLSCUI |
| CHEBI:60723 | CHEBI |
| DB11284 | DRUGBANK_ID |
| C002773 | MESH_SUPPLEMENTAL_RECORD_UI |
| 107767 | PUBCHEM_CID |
| 1427047 | RXNORM |
| BI71WT9P3R | UNII |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| ABELCET | HUMAN PRESCRIPTION DRUG LABEL | 3 | 57665-101 | INJECTION | 1.50 mg | INTRAVENOUS | NDA | 20 sections |
| ABELCET | HUMAN PRESCRIPTION DRUG LABEL | 3 | 57665-101 | INJECTION | 1.50 mg | INTRAVENOUS | NDA | 20 sections |